{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T17:56:29Z","timestamp":1778435789377,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","content-domain":{"domain":["europeanneuropsychopharmacology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.euroneuro.2012.10.016","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T08:00:16Z","timestamp":1353571216000},"page":"1067-1071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Nanopsychiatry\u2014The potential role of nanotechnologies in the future of psychiatry: A systematic review"],"prefix":"10.1016","volume":"23","author":[{"given":"G.","family":"Fond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Macgregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Miot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2012.10.016_bib1","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1016\/j.biomaterials.2010.04.043","article-title":"Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration","volume":"31","author":"Chertok","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2011.03.008","article-title":"Following dynamic biological processes through NMR-based metabonomics: a new tool in nanomedicine?","volume":"153","author":"Duarte","year":"2011","journal-title":"J. Control Release"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib3","unstructured":"Food and Drug Administration, 08-21-2012. \u3008www.fda.org\u3009."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib4","doi-asserted-by":"crossref","first-page":"061922","DOI":"10.1103\/PhysRevE.79.061922","article-title":"Ising-like dynamics in large-scale functional brain networks","volume":"79","author":"Fraiman","year":"2009","journal-title":"Phys. Rev. E Stat. Nonlinear Soft Matter Phys."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib5","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1196\/annals.1292.010","article-title":"CrossNets: high-performance neuromorphic architectures for CMOL circuits","volume":"1006","author":"Likharev","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib6","first-page":"169","article-title":"Magnetic nanoparticles for gene and drug delivery","volume":"3","author":"McBain","year":"2008","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nano.2011.05.001","article-title":"Bionanotechnologies for treatment and diagnosis of Alzheimer's disease","volume":"7","author":"Moghimi","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nmat3054","article-title":"Short-term plasticity and long-term potentiation mimicked in single inorganic synapses","volume":"10","author":"Ohno","year":"2011","journal-title":"Nat. Mater."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib9","doi-asserted-by":"crossref","first-page":"e8577","DOI":"10.1371\/journal.pone.0008577","article-title":"Nanostructural and transcriptomic analyses of human saliva derived exosomes","volume":"5","author":"Palanisamy","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4155\/fmc.10.5","article-title":"Nanomedicine strategies for molecular targets with MRI and optical imaging","volume":"2","author":"Pan","year":"2010","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib11","first-page":"139","article-title":"Molecular Trojan horses for blood\u2013brain barrier drug delivery","volume":"6","author":"Pardridge","year":"2006","journal-title":"Discovery Med."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib12","first-page":"803","article-title":"Nanomedicine: promises and challenges for the future of public health","volume":"5","author":"Pautler","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib13","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2005.07.024","article-title":"Targeted nanoparticles for drug delivery through the blood\u2013brain barrier for Alzheimer's disease","volume":"108","author":"Roney","year":"2005","journal-title":"J. Control Release"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib14","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.tics.2004.07.008","article-title":"Organization, development and function of complex brain networks","volume":"8","author":"Sporns","year":"2004","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-2990.2008.01005.x","article-title":"Review: role of developmental inflammation and blood\u2013brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases","volume":"35","author":"Stolp","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib16","first-page":"689","article-title":"Novel applications of nanotechnology in medicine","volume":"130","author":"Surendiran","year":"2009","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib17","first-page":"15","article-title":"Nanomedicine: application of nanotechnology in medicine. Opportunities in neuropsychiatry","volume":"13","author":"Szebeni","year":"2011","journal-title":"Neuropsychopharmacol. Hung."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib18","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/nbt1006-1211","article-title":"The emerging nanomedicine landscape","volume":"24","author":"Wagner","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.euroneuro.2012.10.016_bib19","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/smll.201100442","article-title":"More effective nanomedicines through particle design","volume":"7","author":"Wang","year":"2011","journal-title":"Small"},{"key":"10.1016\/j.euroneuro.2012.10.016_bib20","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.biomaterials.2009.09.104","article-title":"Trimethylated chitosan-conjugated PLGA nanoparticles for the delivery of drugs to the brain","volume":"31","author":"Wang","year":"2010","journal-title":"Biomaterials"}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12003070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X12003070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T02:52:40Z","timestamp":1540090360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X12003070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0924977X12003070"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.016","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717969179.793470101","asserted-by":"object"}]},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanopsychiatry\u2014The potential role of nanotechnologies in the future of psychiatry: A systematic review","name":"articletitle","label":"Article Title"},{"value":"European Neuropsychopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euroneuro.2012.10.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. and ECNP. All rights reserved.","name":"copyright","label":"Copyright"}]}}